Madrigal Pharmaceuticals
-
2011
Company Description
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including diabetes, dyslipidemia and cardiovascular disease.
-
Manufacturer:
Science and Engineering -
Formed:
2011 -
Company Website:
-
Company E-mail:
-
Company Address:
500 Office Center Drive, Suite 400 FortWashington, PAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits